BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 16675890)

  • 1. Pharmacogenomics of osteoporosis: opportunities and challenges.
    Nguyen TV; Eisman JA
    J Musculoskelet Neuronal Interact; 2006; 6(1):62-72. PubMed ID: 16675890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenetics of osteoporosis: future perspectives.
    Marini F; Brandi ML
    Calcif Tissue Int; 2009 May; 84(5):337-47. PubMed ID: 19271099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenetics of osteoporosis and the prospect of individualized prognosis and individualized therapy.
    Nguyen TV; Center JR; Eisman JA
    Curr Opin Endocrinol Diabetes Obes; 2008 Dec; 15(6):481-8. PubMed ID: 18971675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An overview of osteoporosis: from genetics to clinics.
    Brandi ML
    Aging Clin Exp Res; 2011 Apr; 23(2 Suppl):3-5. PubMed ID: 21970903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic research in osteoporosis: Where are we? Where should we go next?
    Recker RR
    J Musculoskelet Neuronal Interact; 2004 Mar; 4(1):86-90. PubMed ID: 15615081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetics of osteoporosis.
    Huang QY; Kung AW
    Mol Genet Metab; 2006 Aug; 88(4):295-306. PubMed ID: 16762578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [From pharmacogenetics to pharmacogenomics: the start of a new era of personalized medicine in nephrology].
    Zaza G; Granata S; Mangino M; Grandaliano G; Schena FP
    G Ital Nefrol; 2010; 27(4):353-66. PubMed ID: 20672232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent development in pharmacogenomics: from candidate genes to genome-wide association studies.
    Grant SF; Hakonarson H
    Expert Rev Mol Diagn; 2007 Jul; 7(4):371-93. PubMed ID: 17620046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The search for human osteoporosis genes.
    Zmuda JM; Sheu YT; Moffett SP
    J Musculoskelet Neuronal Interact; 2006; 6(1):3-15. PubMed ID: 16675885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenomics - therapeutic and ethical issues.
    Patowary S
    Kathmandu Univ Med J (KUMJ); 2005; 3(4):428-30. PubMed ID: 16449851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress in pharmacogenomics and its promise for medicine.
    Blake CA; Sobel BE
    Exp Biol Med (Maywood); 2008 Dec; 233(12):1482-3. PubMed ID: 18849537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetics of osteoporosis.
    Ralston SH
    Proc Nutr Soc; 2007 May; 66(2):158-65. PubMed ID: 17466098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenomics: bench to bedside.
    Weinshilboum R; Wang L
    Nat Rev Drug Discov; 2004 Sep; 3(9):739-48. PubMed ID: 15340384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applying pharmacogenomics to enhance the use of biomarkers for drug effect and drug safety.
    Beitelshees AL; McLeod HL
    Trends Pharmacol Sci; 2006 Sep; 27(9):498-502. PubMed ID: 16876261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular pathology and pharmacogenomics in Alzheimer's disease: polygenic-related effects of multifactorial treatments on cognition, anxiety and depression.
    Cacabelos R
    Methods Find Exp Clin Pharmacol; 2007 Jul; 29 Suppl A():1-91. PubMed ID: 17957277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenomics in cancer treatment defining genetic bases for inter-individual differences in responses to chemotherapy.
    Ansari M; Krajinovic M
    Curr Opin Pediatr; 2007 Feb; 19(1):15-22. PubMed ID: 17224657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacogenetics of osteoporosis: towards novel theranostics for personalized medicine?
    Rojo Venegas K; Aguilera Gómez M; Cañada Garre M; Sánchez AG; Contreras-Ortega C; Calleja Hernández MA
    OMICS; 2012 Dec; 16(12):638-51. PubMed ID: 23215803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertension pharmacogenomics: current status and future directions.
    Johnson JA; Turner ST
    Curr Opin Mol Ther; 2005 Jun; 7(3):218-25. PubMed ID: 15977418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New and emerging treatments for osteoporosis.
    Clarke BL
    Clin Endocrinol (Oxf); 2009 Sep; 71(3):309-21. PubMed ID: 19222491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.